drugset / Trial / NCT01275612
Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot, explorative, study to test the feasibility and safety of systemic infusion of donor ex-vivo expanded Mesenchymal Stem Cells to repair the kidney and improve function in patients with solid organ cancers who develop acute renal failure after chemotherapy with cisplatin.
Timeline
- Start
- 2010-11
- Primary completion
- 2018-03-19
- Completion
- 2018-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1 cells/kg | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 2 cells/kg | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 5 cells/kg | Intravenous |